Recent temporal trends for first-time hospitalization for acute myocardial infarction. Treatment patterns and

Paolo Ortolani1, Massimiliano Marino, Giovanni Melandri

  • 1Institute of Cardiology, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

American Heart Journal
|November 2, 2013
PubMed

Insights

Trends in acute myocardial infarction (AMI) show increased evidence-based treatments from 2002-2009, reducing early deaths. However, this rise in treatment was associated with a significant increase in bleeding events.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Epidemiology

Background:

  • Acute myocardial infarction (AMI) remains a significant cause of mortality and morbidity.
  • Understanding trends in AMI incidence, treatment, and outcomes is crucial for public health.
  • Recent changes in clinical practice may impact patient outcomes.

Purpose of the Study:

  • To analyze recent trends in the incidence of first-time hospitalization for AMI.
  • To assess the adoption of evidence-based treatments for AMI.
  • To evaluate the impact of these trends on clinical outcomes.

Main Methods:

  • Retrospective population-based cohort study.
  • Utilized medical administrative data from the Emilia-Romagna Region, Italy (approx. 4.5 million inhabitants).
  • Identified 60,673 patients hospitalized for AMI between 2002 and 2009.

Main Results:

  • Standardized AMI incidence peaked in 2004 and then declined.
  • Increased utilization of coronary angiography, angioplasty, aspirin, beta-blockers, and statins.
  • Observed reduction in in-hospital all-cause and cardiovascular mortality, but increased bleeding risk.

Conclusions:

  • Evidence-based treatment for AMI significantly increased between 2002 and 2009.
  • These practice changes led to reduced early mortality.
  • The benefits of improved treatment were offset by a notable increase in bleeding complications.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
961
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
497